48 In the index

Selegiline SELE

An FDA-approved medication for Parkinson's disease, and, as a skin patch (Emsam), for depression. Human studies support both uses, though at higher doses it requires avoiding certain foods to prevent a dangerous rise in blood pressure.

Also known as Deprenyl, Eldepryl

Effects Focus Longevity

Routes Oral

Legal status Prescription drug

WADA Not listed

3D Molecular Structure of C₁₃H₁₇N

Drag to rotate · scroll to zoom

Chemistry

Formula: C13H17N
Molar mass: 187.28
CAS: 14611-51-9
PubChem CID: 26757

Reported dosing

Approved label

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 5 mg twice daily (oral) or 6 mg/24 hours (transdermal patch)

Reported range 5-10 mg/day (oral); 6-12 mg/24 hours (patch)

Route Oral or transdermal patch

Frequency Once or twice daily

Duration Chronic/ongoing (as prescribed)

FDA-approved MAO-B inhibitor (Eldepryl for Parkinson's; Emsam patch for depression); also used off-label in the anti-aging/nootropic community at low doses.

Where this comes from FDA prescribing information

These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.